# FDA Inspection 1203119 - Keith E. Stockerl Goldstein, MD - March 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/keith-e-stockerl-goldstein-md/ea139d6c-1538-4fe9-a77f-363413109d23
Source feed: FDA_Inspections

> FDA Inspection 1203119 for Keith E. Stockerl Goldstein, MD on March 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203119
- Company Name: Keith E. Stockerl Goldstein, MD
- Inspection Date: 2023-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/keith-e-stockerl-goldstein-md/bbd11c81-6cd2-4a70-9d15-7a28409a7533

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c